At KDAH, our goal is to support cancer patients through personalized genomic solutions and treatment strategies tailored to their individual cancer profiles. We offer patient-specific treatment plans that may include targeted therapy, appropriate chemotherapy regimens, hormone therapy, and immunotherapy. These plans are based on tumor molecular characteristics, cancer stage, progression, recurrence, and the patient's overall health, medical history, and preferences.
The Molecular Pathology and Genomics Department at KDAH launches and manages Hereditary Cancer Clinic, which focuses on personalized cancer care for patients with history of cancer or patients with history of cancer in the family. Hereditary cancers are known to be genetic and the mutations are passed down in family members. People with positive variants in genes may present with hereditary cancer syndrome and are at a higher risk of getting certain cancers.
Hereditary cancers are genetic and result from mutations that are passed down through family members. Individuals with mutations in cancer-predisposing genes may have a hereditary cancer syndrome or be at an increased risk for specific types of cancer.
Our Hereditary Cancer Clinic specializes in personalized cancer care for individuals with a cancer diagnosis or a family history of cancer.
To ensure efficient management, follow-up treatment strategies, and familial screening, we maintain genomic findings of positive hereditary cancer patients in a secure REDCap database, known as the KDAH Hereditary Cancer Registry & Germline Variants Knowledge Database.
View Doctors
